Xeglyze

Active Ingredient(s): Abametapir
FDA Approved: * July 24, 2020
Pharm Company: * DR REDDYS LABS SA
Category: Antiprotozoal / Anthelmintic

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Xeglyze Overview

Abametapir, sold under the brand name Xeglyze, is a medication used for the treatment of head lice infestation.[1] Abametapir is a metalloproteinase inhibitor.[1] Abametapir was approved for medical use in the United States in July 2020.[1][2] References ^ a b c "Xeglyze (abametapir) lotion, for topical use" (PDF). U.S. Food and Drug Administration (FDA). Dr. Reddy's Laboratories. Inc. Retrieved 25 July 2020..mw-parser-outpu...

Read more Xeglyze Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Abametapir

Recent Xeglyze Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Abametapir
  • Lotion: 0.74%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Abametapir or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 28 September 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA